9 min read
The Online Proofing Audit Trail: What Regulated Industries Need
Y You have a problem. Whether you are managing a product recall investigation, a regulatory review of a financial promotion, or an FCA audit of...
Every regulated brand owner has had this moment: a label goes to print, a regulator or retailer flags an issue, and someone asks, "Who approved this version?" The honest answer is often a scramble through email threads, shared drives, and a PDF that may or may not be the final one.
That moment is expensive. In pharma, it can mean a recall. In food and beverage, it can mean a retailer delisting a SKU. In any regulated category, it usually means lost time, lost trust, and a compliance team asking hard questions about a process that was supposed to catch this.
The word "compliant" gets used loosely around artwork approval. Teams say their process is compliant because they use e-signatures, or because someone keeps a spreadsheet of sign-offs. But compliance in a regulated context has a specific, testable meaning, and it's narrower than most teams assume.
On the Dalim blog today, our article breaks down what compliant artwork approval actually requires, where most processes fall short, and how to build a defensible workflow that holds up under audit, not just under normal operating conditions.
Compliant artwork approval means every version of an artwork file has a complete, tamper-evident record of who reviewed it, what they approved or rejected, when the action happened, and under what authority. It requires structured routing to the right reviewers, version control that prevents outdated files from reaching production, and an audit trail that can be reproduced on demand for a regulator or auditor.
Artwork approval looks simple from the outside: someone designs it, someone checks it, someone signs off. In practice, regulated categories add layers that generic creative review was never built to handle.
A single piece of pharmaceutical packaging might need sign-off from regulatory affairs, quality assurance, legal, medical, and local market teams, often across multiple languages and jurisdictions. A retail food label might need input from nutrition science, legal, brand, and a retailer's own compliance team before it can print. Each additional reviewer is another opportunity for a file to be approved out of sequence, reviewed against the wrong version, or signed off by someone without the authority to do so.
Most breakdowns happen for a handful of predictable reasons:
None of these are unusual. They are the default outcome of running a regulated approval process through tools built for general project collaboration.

This is one of the most misunderstood parts of artwork compliance. Many project management and file-sharing tools show an activity feed: a list of recent actions, useful for keeping a project moving day to day.
An audit trail is a different thing entirely. It is a structured, permanent, tamper-evident record tied to a specific file version, naming exactly who did what, when, and under what role. It cannot be edited or deleted after the fact, and it needs to be reproducible in full during an inspection or audit, sometimes years after the file went to print. For pharma and other FDA-regulated categories, this distinction sits close to the requirements laid out in the FDA's guidance on electronic records and electronic signatures under 21 CFR Part 11.
If your current process cannot answer these questions with confidence, it likely does not meet the bar for regulated use:
| Manual approach (email, shared drives, spreadsheets) | Automated compliant workflow | |
|---|---|---|
| Version control | Depends on file naming discipline and individual diligence | Enforced automatically, with locked prior versions |
| Audit trail | Fragmented across inboxes and chat threads | Centralized, immutable, tied to the file version |
| Reviewer routing | Manually assigned and chased | Structured and automated, with escalation on delays |
| Reconstructing history | Time-consuming, often incomplete | Reproducible on demand |
| Scalability across markets | Breaks down past a handful of SKUs or markets | Designed to scale across regions and volume |
The manual approach is not necessarily careless. It is simply a process built for a lower level of complexity than most regulated brands now operate at.
Building a defensible process does not require starting from scratch. It requires making sure these elements are in place, in this order.

| Common mistake | Best practice |
|---|---|
| Treating email approval as sufficient documentation | Using a centralized system that timestamps and locks every approval action |
| Reviewing artwork as a flat image | Reviewing in context, with barcode, dieline, and technical layers visible |
| Letting reviewers approve without defined authority | Tying approval rights to role, not just individual login access |
| Discovering version confusion only after print | Enforcing version control automatically at file intake |
| Assuming compliance because no incident has happened yet | Testing the process by attempting to reconstruct a full approval history before an auditor asks |
None of this requires exotic technology. It requires a system that treats compliance as a structural feature, not an add-on.
This is the area where modern workflow platforms genuinely change the risk profile. Structured routing removes the dependency on one project manager remembering who needs to see what. Automated escalation catches delays before they become a bottleneck close to a print deadline. And a proper audit trail, embedded in the platform rather than reconstructed after the fact, turns a defensive scramble into a five-minute export.
This is the space DALIM FUSION was built for. Rather than bolting proofing onto a general-purpose project tool, DALIM FUSION integrates online proofing, structured approval workflows, and file management in one platform, with audit trail capture, version locking, and role-based access built in as core functionality rather than optional extras. For packaging teams especially, that means the evidence an auditor asks for is something the system can produce, not something someone has to piece together after the fact.
It's worth being precise here: no software makes a process compliant on its own. Compliance depends on how a team defines its reviewer roles, its escalation rules, and its documentation standards. What the right platform does is make it possible to actually follow that process consistently, at scale, without relying on individual memory or manual diligence to hold everything together.

Compliant artwork approval is not a certificate you earn once. It is a standard the process has to meet every single time a file moves through review, whether that's the tenth SKU this year or the thousandth.
The teams that get this right treat the audit trail as a first-class requirement, not an afterthought. They define reviewer authority clearly. They build in escalation before delays become risk. And they test their own process periodically by asking: if an auditor asked for the full history of this file right now, could we produce it in minutes rather than days?
If the answer is no, that's not a reason for alarm. It's a starting point for a more defensible process. If you want to walk through what that looks like in practice, it's worth a conversation with the DALIM team.
What is the difference between artwork approval and general document approval?
Artwork approval involves reviewing a production file in its full technical context, including barcodes, dielines, color separations, and layout, not just text content. General document approval typically only requires reviewing written content, which makes standard document tools insufficient for artwork in regulated categories.
Do all regulated industries need the same level of artwork approval control?
No. The specific requirements vary by sector and jurisdiction, but pharma, medical device, and food and beverage categories generally carry the highest documentation burden due to patient and consumer safety implications. Regardless of sector, any brand distributing through major retailers will also face retailer-specific compliance requirements around labeling and barcodes.
Does an online proofing platform need to be 21 CFR Part 11 compliant for pharma use?
If your organization is using electronic records or electronic signatures to satisfy an FDA predicate rule requirement, those records need to meet Part 11 controls, as outlined in the FDA's scope and application guidance. Not every internal artwork review will fall under Part 11, but any approval step tied to a regulatory submission or required record typically will.
What counts as an acceptable electronic signature for regulated artwork approval?
An acceptable electronic signature needs to be uniquely tied to an individual, include a timestamp, and be linked to the specific record it applies to in a way that cannot be altered after the fact. A typed name or a generic login click does not meet this bar on its own.
How long should artwork approval records be retained?
Retention requirements depend on the regulation and product category involved, and can range from several years to the lifetime of the product plus a defined period after discontinuation. Rather than guessing, brands should confirm retention periods with their regulatory affairs team for each relevant market.
Can a small marketing team realistically implement a compliant artwork approval process without a large compliance department?
Yes. The core requirements, version control, structured routing, and a real audit trail, are process and platform decisions, not headcount decisions. A small team using the right workflow tools can often meet these standards more consistently than a larger team relying on manual tracking.
What is the most common cause of artwork approval failures that lead to recalls?
Version confusion is the most frequent root cause: an outdated file gets approved or printed because the review process did not clearly lock or supersede prior versions. This is largely preventable with automated version control rather than manual file naming conventions.
How do multi-market or multi-language artwork approvals stay compliant?
Each localized version needs its own documented review by the appropriate regional or legal reviewer, run in parallel where possible, with all feedback captured against the specific version being reviewed rather than a shared master file. Treating localized versions as separate, trackable artifacts rather than variations of one file is key to keeping the audit trail accurate.
9 min read
Y You have a problem. Whether you are managing a product recall investigation, a regulatory review of a financial promotion, or an FCA audit of...
1 min read
1 min read
A single missed decimal in a nutrition panel. A pantone that shifted half a shade on a different substrate. A barcode that scans fine on a monitor...